Evidence map›Paper›PMID 38074158›Full record

ArticleFrontiers in pharmacology2023

Antihypertensive therapy responsiveness and adverse outcomes in preeclampsia: insights into molecular mechanisms underlying cardiovascular and renal complications.

Marcelo R Luizon, Daniela A Pereira, Izabela Mamede, Carla S Ceron, Ricardo C Cavalli, Ana C Palei, Valeria C Sandrim

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marcelo R LuizonDepartment of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Daniela A Pereira *Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Izabela MamedeDepartment of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Carla S CeronDepartment of Biological Sciences, Institute of Exact and Biological Sciences, Federal University of Ouro Preto, Ouro Preto, Minas Gerais, Brazil.
Ricardo C CavalliDepartment of Gynecology and Obstetrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, São Paulo, Brazil.
Ana C Palei *Department of Surgery, University of Mississippi Medical Center, Jackson, MS, United States.
Valeria C Sandrim *Department of Biophysics and Pharmacology, Institute of Biosciences, Universidade Estadual Paulista (UNESP), Botucatu, São Paulo, Brazil.

Funding

Tracking and Evaluation CoreU54GM115428 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI COMPRETTA, CAROLINE E. · 2016 to 2025
$38.2M
Guideline-directed management and therapy (GDMT) for the prevention of postpartum cardiac dysfunction in preeclamptic African American womenR01HL148191 · NHLBI · UNIVERSITY OF CHICAGO · PI SHAHUL, SAJID · 2021 to 2025
$3.8M
Platelet-mediated mechanisms of placental and systemic hypercoagulability in preeclampsiaK01HL159032 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI PALEI, ANA CAROLINA · 2022 to 2024
$319k
NHLBI NIH HHS K01 HL159032NHLBI NIH HHS R01 HL148191NIGMS NIH HHS U54 GM115428
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antihypertensive agentsendothelial dysfunctiongenetic polymorphismsmatrix metalloproteinase (MMP)-2nicotinamide phosphoribosyltransferase (NAMPT)nitric oxidepreeclampsiatissue inhibitor of metalloproteinase (TIMP)-3

Identifiers

PMID38074158
PMCPMC10702581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.